Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
Viral Immunology|May 3, 2016
Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor BindingKirsi Tamminen, Maria Malm, Timo Vesikari, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2018
Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigensKirsi Tamminen, Maria Malm, Timo Vesikari, et al.
Journal of Immunology Research|April 24, 2018
Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in MiceSuvi Heinimäki, Maria Malm, Timo Vesikari, et al.
Molecular Immunology|August 31, 2016
Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 proteinMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Antiviral Research|June 24, 2018
Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potentialSuvi Heinimäki, Maria Malm, Timo Vesikari, et al.
Viral Immunology|November 16, 2018
Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse SeraMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
The Journal of Infectious Diseases|June 28, 2014
High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in childrenMaria Malm, Hanni Uusi-Kerttula, Timo Vesikari, et al.
Human Vaccines & Immunotherapeutics|October 16, 2015
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccineVesna Blazevic, Maria Malm, Daisuke Arinobu, et al.
Vaccine|August 23, 2011
Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritisVesna Blazevic, Suvi Lappalainen, Kirsi Nurminen, et al.
Vaccine|December 17, 2017
Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypesMaria Malm, Kirsi Tamminen, Suvi Heinimäki, et al.
Pageof 22